- Home
- VRAX vs RYDE Comparison
VRAX vs RYDE Comparison
Compare VRAX & RYDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- RYDE
- Stock Information
- Founded
- VRAX 2013
- RYDE 2014
- Country
- VRAX United Kingdom
- RYDE Singapore
- Employees
- VRAX N/A
- RYDE N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RYDE
- Sector
- VRAX Health Care
- RYDE
- Exchange
- VRAX Nasdaq
- RYDE NYSE
- Market Cap
- VRAX 4.4M
- RYDE 5.2M
- IPO Year
- VRAX 2022
- RYDE 2024
- Fundamental
- Price
- VRAX $0.95
- RYDE $0.34
- Analyst Decision
- VRAX Strong Buy
- RYDE
- Analyst Count
- VRAX 1
- RYDE 0
- Target Price
- VRAX $3.00
- RYDE N/A
- AVG Volume (30 Days)
- VRAX 155.0K
- RYDE 762.5K
- Earning Date
- VRAX 02-05-2025
- RYDE 05-02-2025
- Dividend Yield
- VRAX N/A
- RYDE N/A
- EPS Growth
- VRAX N/A
- RYDE N/A
- EPS
- VRAX N/A
- RYDE N/A
- Revenue
- VRAX $6,331.00
- RYDE $6,557,978.00
- Revenue This Year
- VRAX $217,274.83
- RYDE $21.13
- Revenue Next Year
- VRAX N/A
- RYDE $13.43
- P/E Ratio
- VRAX N/A
- RYDE N/A
- Revenue Growth
- VRAX N/A
- RYDE 3.27
- 52 Week Low
- VRAX $0.74
- RYDE $0.16
- 52 Week High
- VRAX $9.00
- RYDE $22.49
- Technical
- Relative Strength Index (RSI)
- VRAX 51.51
- RYDE N/A
- Support Level
- VRAX $0.86
- RYDE N/A
- Resistance Level
- VRAX $1.10
- RYDE N/A
- Average True Range (ATR)
- VRAX 0.11
- RYDE 0.00
- MACD
- VRAX 0.01
- RYDE 0.00
- Stochastic Oscillator
- VRAX 35.48
- RYDE 0.00
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About RYDE RYDE GROUP LTD
Ryde Group Ltd operates a technology platform that provides a range of ride-hailing, carpooling and delivery focused offerings in Singapore. The company operates in twos segments namely Mobility provides on-demand and scheduled carpooling and ride-hailing services, matching riders to its driver partners; and Quick Commerce provides on-demand, scheduled, and multi-stop parcel delivery services.